2
Announcements
Trials
Browse
Landscape
Status
Recruiting
3
Completed
3
Active not recruiting
2
Withdrawn
1
Terminated
1
Temporarily not available
1
Sponsor Class
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
1
Interventions
Gemcitabine
2
telisotuzumab vedotin
1
pembrolizumab
1
Taxes
1
Insulin Infusion Systems
1
FANG vaccine
1
Erlotinib Hydrochloride
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Temporarily not available
×
telisotuzumab vedotin
×
Clear all
NCT04830202
2026-05-13
Expanded Access to Telisotuzumab Vedotin
AbbVie
Temporarily not available